Searched for
PIRAMAL PHARMA
Swara Baby gets Sebi nod for Rs 1,000 crore IPO as hygiene products maker eyes expansionSwara Baby Products has received approval from Sebi to proceed with its Rs 1,000 crore IPO. The IPO includes a fresh issue of equity shares...- MFs turn selective, pick Coal India, LIC among large-caps in AugustAmid the backdrop of increasing US interest rates in August, fund managers proceeded with caution, prioritizing large-cap stocks that offer...
- JioBlackRock Flexi Cap Fund exits NALCO, Hindustan Zinc; trims exposure in BSE, RILJioBlackRock Flexi Cap Fund reshuffled its portfolio in August, exiting 21 stocks while reducing exposure to 34 others, including NALCO, Hi...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian markets extended their losing streak for a third day as soaring oil prices and Middle East tensions hurt sentiment. Sensex fell 813 ...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian equities extended their decline on Tuesday, with Sensex falling 555 points and Nifty ending below 23,650. Analysts cited elevated cr...
- Ahead of Market: 10 things that will decide stock market action on TuesdaySensex and Nifty extended their four-week losing streak as rising oil prices and US-Iran tensions weighed on sentiment. Analysts flagged do...
- Midcap Street party turns selective as 15 stocks power 50% of rallyIndian midcap and smallcap indices are near record highs currently. A few select stocks are driving most of these significant gains. This c...
- Kaynes Tech, Wockhardt, Persistent Systems shares fall up to 5% as broader markets tumble. What lies ahead?The stock market saw marked declines on Monday, particularly among smallcap and midcap shares. Persistent Systems and National Aluminium Co...
- Stocks in news: HDFC Bank, Ola Electric Mobility, NBCC and Knowledge Realty TrustIndian equity markets closed higher on Friday, ending a losing streak with IT stock gains. HDFC Bank's CEO will not seek reappointment, whi...
- US envoy Sergio Gor meets Piramal Group Chairman Ajay Piramal, discusses expansion plans in USUS Ambassador Sergio Gor met Piramal Group Chairman Ajay Piramal discussing economic ties. Gor lauded Piramal's growing United States footp...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Lupin launches generic Sugammadex injection in USLupin Limited announced the launch of its Sugammadex Injection in the United States. This follows approval from the US Food and Drug Admini...
- Piramal Pharma to focus on policy, not Trump tariff tweets: Nandini PiramalPiramal Pharma will focus on policy actions amid tariff concerns. Its global manufacturing network offers a significant advantage. The comp...
- Pharma stocks slide as Trump's 100% generic drug tariff plan spooks investorsIndian drug shares declined Wednesday following US President Trump's tariff announcement. These proposed tariffs will significantly impact ...
- Piramal Pharma shares in focus after USFDA issues form 483 for Kentucky unitPiramal Pharma's US facility inspection concluded with four observations from the FDA. The company expects a voluntary action indicated cla...
- Piramal Pharma targets to double revenue in 5 yearsPiramal Pharma aims to achieve $2 billion in annual revenue with a 25% operating margin by fiscal 2030, driven by its CDMO business. The co...
- Piramal Pharma posts Rs 10 crore net profit in Q3FY24Piramal Pharma Q3 Results: Revenue from operations rose 14% YoY driven by double digit growth across all the three businesses.
- After a tough year, Piramal Pharma hopes to regain vigour in 2nd halfPiramal Pharma chairperson Nandini Piramal in an interview to ET said the company is aiming for mid-teen revenue growth and a meaningful im...
- Piramal Pharma Q3 Results: Firm reports Rs 90 cr loss, gets board nod to raise up to Rs 1,050 crPiramal Pharma said while the YoY financials are not strictly comparable due to the non-inclusion of certain "non-common control transactio...
- Piramal Pharma stock rises over 3%. Here’s whyThe brokerage firm Jefferies assigned buy rating to Piramal Pharma with a target price of Rs 150, implying an upside potential of 20% from ...
Load More
